CCEP (CCEP) Stock Price & Analysis
CCEP (CCEP) rose 1.70% to USD 96.87 as of June 9, 2026 at 23:49 UTC, according to Nexqual real-time market data.
CCEP last closed at USD 95.25; the session ranged USD 95.9–97.89 on volume of 1,817,038 shares. Market capitalization is $42.89B, with a 52-week range of USD 84.66–110.9 (NMS). Source: Nexqual, June 9, 2026 at 23:49 UTC.
Key Statistics (as of June 9, 2026 at 23:49 UTC)
| Price | USD 96.87 |
|---|---|
| Change | ▲ 1.70% (up) |
| Previous Close | USD 95.25 |
| Open | USD 96.22 |
| Day Range | USD 95.9 – 97.89 |
| 52-Week Range | USD 84.66 – 110.9 |
| Volume | 1,817,038 shares |
| Market Cap | $42.89B |
| Exchange | NMS |
Technical Analysis (CCEP)
Nexqual's technical model rates CCEP "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 23:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.18 (neutral) |
| vs SMA50 | Above (USD 94.16) |
| MACD | 0.05 (positive) |
Analyst Ratings (CCEP)
Wall Street analysts rate CCEP "Buy" based on 10 analysts, with a mean price target of USD 104.06 (range USD 84.03–112.34), per Nexqual as of June 9, 2026 at 23:49 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 104.06 |
| High Target | USD 112.34 |
| Low Target | USD 84.03 |
| Buy / Hold / Sell | 7 / 4 / 0 |
Earnings (CCEP)
| Revenue Estimate | $5.71B |
|---|
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Financials & Fundamentals (CCEP)
| Total Revenue | $20.90B |
|---|---|
| Revenue Growth (YoY) | +0.20% |
| Gross Margin | +35.58% |
| Operating Margin | +13.72% |
| Profit Margin | +9.29% |
| ROE | +22.89% |
| Debt / Equity | 130 |
| Current Ratio | 0.8 |
| Total Cash | $972.00M |
| Total Debt | $10.79B |
| Free Cash Flow | $1.75B |
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Financial Health Score (CCEP)
Nexqual rates CCEP's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:49 UTC.
| Growth | Mixed — Revenue +2.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 14% |
| Balance Sheet | Weak — $972M cash vs $10.8B debt |
| Cash Flow | Solid — FCF $1.75B, 8% margin |
| Efficiency | Strong — ROE 23%, ROA 5.7% |
Ownership (CCEP)
| Insider Ownership | +55.58% |
|---|---|
| Institutional Ownership | +38.58% |
| Shares Outstanding | 442.78M |
| Float | 199.63M |
| Short % of Float | +5.03% |
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Leadership (CCEP)
CCEP is led by Damian Paul Gammell (age 55), CEO & Executive Director, per Nexqual as of June 9, 2026 at 23:49 UTC.
| CEO & Executive Director | Damian Paul Gammell (age 55) |
|---|---|
| Chief Financial Officer | Ed Walker |
| Vice President of Investor Relations | Sarah Willett |
| Chief Strategy Officer | Leendert den Hollander (age 56) |
| Vice President of Sustainability of CCEP | Joe Franses |
Major Backers & Investors (CCEP)
Notable institutional backers of CCEP include Invesco, Goldman Sachs, Boston Partners, according to Nexqual as of June 9, 2026 at 23:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 6.08% |
| Goldman Sachs | 1.91% |
| Boston Partners | 1.29% |
| Truist Financial Corp | 1.07% |
| Massachusetts Financial Services Co. | 1.05% |
| FIL LTD | 0.87% |
| Morgan Stanley | 0.82% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 3.5% |
| Vanguard Group | 2.57% |
| State Street | 1.02% |
Source: Nexqual, June 9, 2026 at 23:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KOF | Coca Cola Femsa S.A.B. de C.V. | USD 104.35 | ▼ 1.99% |
| KDP | Keurig Dr Pepper Inc. | USD 31.48 | ▲ 3.11% |
| FMX | Fomento Economico Mexicano S.A. | USD 122.2 | ▼ 0.55% |
| BSAC | Banco Santander - Chile | USD 31.4 | ▲ 4.6% |
| CDW | CDW Corporation | USD 133.33 | ▲ 0.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:49 UTC. This page is informational and not investment advice.